TD Cowen analyst Brendan Smith downgraded Evotec (NASDAQ: EVO) from Buy to Hold with a price target of $2.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades